SmithSC, BenjaminEJ, BonowROet al.AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation, 2011; 124:2458–2473.
2.
MoscaL, BenjaminEJ, BerraKet al.Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: A guideline from the American Heart Association. J Am Coll Cardiol, 2011; 57:1404–1423.
3.
YusufS, DagenaisG, PogueJ, BoschJ, SleightP. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000; 342:154–160.
4.
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet, 1999; 354:447–455.
5.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet, 2002; 360:7–22.
6.
CookNR, AlbertCM, GazianoJMet al.A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med, 2007; 167:1610–1618.
7.
BjelakovicG, NikolovaD, GluudLL, SimonettiRG, GluudC. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA, 2007; 297:842–857.
8.
MursuJ, RobienK, HarnackLJ, ParkK, JacobsDRJr. Dietary Supplements and Mortality Rate in Older Women: The Iowa Women's Health Study. Arch Intern Med, 2011; 171:1625–1633.
9.
BergerJS, RoncaglioniMC, AvanziniF, PangrazziI, TognoniG, BrownDL. Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials. JAMA, 2006; 295:306–313.
